ICU Medical, Inc. (ICUI) vs Pulse Biosciences, Inc (PLSE)

ICU Medical, Inc. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. ICU Medical, Inc. is the larger, with a market value of $4.2B against $3.3B — 1.3× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; ICU Medical, Inc. trades at 136×. ICU Medical, Inc. grew revenue faster over the last twelve months: −8.97% against −23.3%. ICU Medical, Inc. has the higher net margin (1.39% vs −6,755.8%) and the higher return on invested capital (1.46% vs 0.00%). Across the 18 metrics below, ICU Medical, Inc. leads on 14 and Pulse Biosciences, Inc on 4.

Valuation

Metric ICUI PLSE Medical Instruments & Supplies median
P/E 135.83 n/m 33.75
P/S 1.89 2,585.22 2.52
P/B 1.89 30.79 2.48
Price to free cash flow 26.65 n/m 25.19
EV/EBITDA 18.04 n/m 14.62
EV/Sales 2.32 2,554.99 2.88
Earnings yield 0.74% (2.67%) (2.67%)
Free cash flow yield 3.75% (2.00%) 0.09%

Profitability

Metric ICUI PLSE Medical Instruments & Supplies median
Gross margin 39.13% 0.25% 54.29%
Operating margin 3.34% (7,007.76%) 1.07%
Net margin 1.39% (6,755.78%) (1.61%)
Free cash flow margin 7.08% (5,180.42%) 1.08%
Return on equity 1.41% (78.49%) (1.32%)
Return on assets 0.74% (67.90%) 0.00%
Return on invested capital 1.46% 0.00% 0.00%

Growth

Metric ICUI PLSE Medical Instruments & Supplies median
Revenue growth (TTM) (8.97%) (23.25%) 8.85%
EPS growth (last fiscal year) 100.62% (17.39%) 8.65%
Revenue growth, 5-year CAGR 11.91% — 9.17%
Net income growth, 5-year CAGR (61.53%) 0.00% 0.00%

Health

Metric ICUI PLSE Medical Instruments & Supplies median
Debt to equity 0.57 0.00 0.10
Current ratio 2.43 9.63 2.48
Net debt to EBITDA 3.91 1.06 0.89

Dividend

Metric ICUI PLSE Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric ICUI PLSE Medical Instruments & Supplies median
Market cap 4.18b 3.31b 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack